Oncimmune Holdings (LSE:ONC) Pre-Tax Income : £-3.98 Mil (TTM As of Aug. 2024)

Oncimmune Holdings Pre-Tax Income Chart

Oncimmune Holdings Annual Data
	Trend	May15	May16	May17	May18	May19	May20	May21	May22	Aug23	Aug24
Pre-Tax Income		Get a 7-Day Free Trial					-9.78	-6.06	-9.53	-5.93	-3.98

Oncimmune Holdings Semi-Annual Data
	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24	Aug24
Pre-Tax Income	Get a 7-Day Free Trial															-4.65	-4.05	-1.88	-1.11	-2.87

Competitive Comparison of Oncimmune Holdings's Pre-Tax Income

For the Biotechnology subindustry, Oncimmune Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's Pre-Tax Income falls into.

Oncimmune Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Oncimmune Holdings's Pretax Income for the fiscal year that ended in Aug. 2024 is calculated as

Oncimmune Holdings's Pretax Income for the quarter that ended in Aug. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-3.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings  (LSE:ONC) Pre-Tax Income Explanation

Oncimmune Holdings's Pretax Margin for the quarter that ended in Aug. 2024 is calculated as

During the past 13 years, Oncimmune Holdings's highest Pretax Margin was -145.13%. The lowest was -4998.83%. And the median was -1218.29%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings Business Description